Trials / Completed
CompletedNCT01595217
MRCP Diagnoses EHCC Better When Combined DWI
The Incremental Value of 3T Diffusion-Weighted MRI in Diagnosing Extrahepatic Cholangiocarcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- China Medical University, China · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Researching the diagnostic significance of Biliary Tract Neoplasm under combining DWI sequence with MRCP versus MRCP only separately.
Detailed description
The purpose of the study is to evaluate the usefulness of diffusion weighted imaging(DWI) combined with MRCP of 3.0T magnetic resonance imaging (MRI) in the evaluation of suspected malignant bile duct diseases. People with suspected Biliary Tract Neoplasm based on clinical symptoms (such as jaundice and thinness with unknown reasons) and CA-199 value raises are included.Diagnosis divided into two steps: the first one,only provide conventional MR sequences and MRCP images to make a diagnosis; the second step,provide the DWI images additionally, combining the image data before to make a diagnosis. Hypothesis is that DWI sequence should be regularly added into MRCP examination for improving diagnosis rate of Biliary Tract Neoplasm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3T MRI | diffusion weighted imaging(DWI) of biliary tract with GE Signa 3-tesla device |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Completion
- 2013-05-01
- First posted
- 2012-05-09
- Last updated
- 2017-05-16
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01595217. Inclusion in this directory is not an endorsement.